Part, Chapter, Paragraph

 1 I, 2,2    |          human and non-human). First, hyperacute rejection, which is caused
 2 I, 2,2    |             analogous to allografts. ~Hyperacute Rejection. Recipient xenoreactive
 3 I, 2,2    |          major factors that result in hyperacute rejection of an immediately-vascularized
 4 I, 2,2(13)|               al., Immunopathology of hyperacute xenograft rejection in a
 5 I, 2,2(13)|          complement activation in the hyperacute rejection of porcine organs
 6 I, 2,2    |       provides one method to overcome hyperacute rejection.(15) Hyperacute
 7 I, 2,2    |             hyperacute rejection.(15) Hyperacute rejection has also been
 8 I, 2,2(16)|         complement receptor type 1 on hyperacute rejection of porcine xenografts,
 9 I, 2,2(16)|         K76COOH, in the prevention of hyperacute rejection following discordant
10 I, 2,2    |               approach for overcoming hyperacute rejection of pig organs
11 I, 2,2    |           pigs usually do not undergo hyperacute rejection.(18) Based on
12 I, 2,2(17)|               prevention of xenograft hyperacute rejection, Transplantation
13 I, 2,2    | hDAF-expressing pigs, it appears that hyperacute rejection can be overcome,
14 I, 2,2    |          Another possible solution to hyperacute rejection is to eliminate,
15 I, 2,2(18)|               prevention of xenogenic hyperacute organ rejection, Proc Natl
16 I, 2,3    |            non-human primate in which hyperacute rejection has been overcome.
17 I, 2,3    |        expressing hDAF.(33) Even when hyperacute rejection is avoided, the
18 I, 2,3(33)|           factor on the inhibition of hyperacute rejection of pig organs.